Overview
Related People
News & Insights
Mirick represents well-established companies as well as start-up enterprises and institutions in the life sciences sector to help meet their legal and business objectives. We advise on business transactions, mergers and acquisitions, securing start-up venture capital and private equity financing, labor and employment issues, and real estate and land use matters. Our litigation attorneys also have a successful track record in defending life science clients.
Experience
- Successfully negotiated and documented a series of multi-million dollar acquisitions that expanded the scope and types of services offered by a large medical services provider
- Successfully negotiated and documented equity and debt-based capital infusions for early-stage life science organizations
- Developed and implemented licensing and product development programs for a start-up biotechnology company
- Developed and executed a complex litigation-based strategy to secure sole ownership of an IP portfolio relating to client’s core business technology
- Strategically initiated re-examination proceedings of patents asserted against a client in infringement proceedings resulting in successful resolution of the litigation
- Secured a permanent injunction and contempt of court decision, a verdict of willful patent infringement, and a multi-million dollar damage award against a client’s primary competitor
- Assisted a medical device manufacturer with in-licensing intellectual property from a university
- Provided strategic advice to a university regarding costs and advantages of foreign patent prosecution
- Built a portfolio of U.S. and foreign patents for a publicly-traded innovative drug developer that was licensed by a large pharmaceutical company
- Developed a patent portfolio with founding inventors for an orthodontic consumer baby product, and successfully out-licensed the portfolio to an international manufacturer
- Assisted a non-profit licensing office with strategic development and positioning of an international patent portfolio, based on a university small-molecule research program, for a pharmaceutical partnership
- Obtained U.S. and foreign patent protection for a university for new anti-anxiety compounds with reduced side effects
- Successfully negotiated business agreements for further development and distribution of custom medical devices, laboratory instruments and dental products
- Developed and implemented licensing and product development programs for a start-up biotechnology company
- Successfully represented a specialized research organization that offers proprietary model systems for research in diabetes, arthritis, cardiovascular disease and cancer in the private placement of Series A Preferred Stock to private foundations and individuals
- Successfully placed shares of Series D Preferred Stock to venture capital firms, private foundations and individuals for a company that develops protein sensors for diagnostics and therapeutics
Attorneys
Paralegals
EEOC Publishes Guidance Regarding DEI-Related Discrimination
April 1, 2025 | Articles
2024 Employment Law Seminar
October 8, 2024 | Events
David Surprenant Named the Best Lawyers® 2025 Business Law “Lawyer of the Year” in Worcester; 18 Mirick Attorneys Selected for Inclusion in 2025 Edition of Best Lawyers® and 6 Selected for Ones to Watch in America®
August 15, 2024 | In The News
FTC’s Non-Compete Ban Ruled Unenforceable by Federal Judge
August 2, 2024 | Articles
A Reminder that the DOL’s Final Rule Increasing the Salary Thresholds for Salaried, Exempt Executive, Administrative, and Professional Employees Took Effect on July 1, 2024
July 3, 2024 | Articles
Federal Trade Commission Bans Non-Competition Clauses
April 30, 2024 | Articles
Overtime Protection Expanded for Millions of Workers
April 25, 2024 | Articles
Bob Kilroy and Paul Carey Named Mirick’s Co-Managing Partners
April 1, 2024 | In The News
New California Non-Compete Law Prohibits Almost All Non-Compete Agreements and Requires Notice to Certain Current and Former Employees by February 14
February 6, 2024 | Articles
Important Notice Impacting Business Entities: A new beneficial ownership reporting requirement commences on January 1, 2024
December 12, 2023 | Articles
Load More
